Digital Journal
Amphastar Pharmaceuticals Reports Financial Results for the Three Months Ended March 31, 2024
Reports Net Revenues of $171.8 Million for the Three Months Ended March 31, 2024 RANCHO CUCAMONGA, CA / ACCESSWIRE / May 8, 2024 / Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) ("Amphastar" ...
11 hours ago